Publications by authors named "Ellen Bunyi-Teopengco"
Article Synopsis
- The incidence of primary CNS diffuse large B-cell lymphoma (DLBCL) is increasing in immunocompetent individuals, but there are currently no effective prognostic markers to predict outcomes.
- A study of 14 cases revealed that expression of oncogenic proteins p53, c-Myc, and Bcl-6 is associated with significantly poorer overall survival compared to cases without these expressions.
- The findings suggest that evaluating p53, c-Myc, and Bcl-6 levels through immunohistochemistry could be useful for predicting the prognosis in patients with primary CNS DLBCL, indicating a need for further research to validate these results.
CD5 expression in neoplastic large B-cells in T-cell/histiocyte-rich large B-cell lymphoma has not been reported, to the best of our knowledge. Here we describe the first case of CD5+ T-cell/histiocyte-rich large B-cell lymphoma that is well documented by histomorphology, immunohistochemistry, flow cytometry immunophenotyping and sorting, and immunoglobulin heavy-chain gene rearrangement study by polymerase chain reaction. The expression of CD5 in large neoplastic B-cells was demonstrated by immunohistochemistry and multicolor flow cytometry.
View Article and Find Full Text PDF